499 related articles for article (PubMed ID: 28104302)
21. Cyst growth in ADPKD is prevented by pharmacological and genetic inhibition of TMEM16A in vivo.
Cabrita I; Kraus A; Scholz JK; Skoczynski K; Schreiber R; Kunzelmann K; Buchholz B
Nat Commun; 2020 Aug; 11(1):4320. PubMed ID: 32859916
[TBL] [Abstract][Full Text] [Related]
22. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461
[TBL] [Abstract][Full Text] [Related]
23. TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease.
Lee EJ; Seo E; Kim JW; Nam SA; Lee JY; Jun J; Oh S; Park M; Jho EH; Yoo KH; Park JH; Kim YK
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29001-29012. PubMed ID: 33122431
[TBL] [Abstract][Full Text] [Related]
24. Ferroptosis Promotes Cyst Growth in Autosomal Dominant Polycystic Kidney Disease Mouse Models.
Zhang X; Li LX; Ding H; Torres VE; Yu C; Li X
J Am Soc Nephrol; 2021 Nov; 32(11):2759-2776. PubMed ID: 34716241
[TBL] [Abstract][Full Text] [Related]
25. Rosiglitazone inhibits cell proliferation by inducing G1 cell cycle arrest and apoptosis in ADPKD cyst-lining epithelia cells.
Liu Y; Dai B; Fu L; Jia J; Mei C
Basic Clin Pharmacol Toxicol; 2010 Jun; 106(6):523-30. PubMed ID: 20210794
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin E(2) mediates proliferation and chloride secretion in ADPKD cystic renal epithelia.
Liu Y; Rajagopal M; Lee K; Battini L; Flores D; Gusella GL; Pao AC; Rohatgi R
Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1425-34. PubMed ID: 22933297
[TBL] [Abstract][Full Text] [Related]
27. Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation.
Liu C; Zhang Y; Yuan L; Fu L; Mei C
Mol Med Rep; 2013 Sep; 8(3):861-4. PubMed ID: 23864113
[TBL] [Abstract][Full Text] [Related]
28. Cell Proliferation and Apoptosis in ADPKD.
Lee EJ
Adv Exp Med Biol; 2016; 933():25-34. PubMed ID: 27730432
[TBL] [Abstract][Full Text] [Related]
29. The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1.
Wu M; Chen M; Jing Y; Gu J; Mei S; Yao Q; Zhou J; Yang M; Sun L; Wang W; Hu H; Wüthrich RP; Mei C
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1284-94. PubMed ID: 26984954
[TBL] [Abstract][Full Text] [Related]
30. Novel inhibitors of nuclear transport cause cell cycle arrest and decrease cyst growth in ADPKD associated with decreased CDK4 levels.
Tan M; Wettersten HI; Chu K; Huso DL; Watnick T; Friedlander S; Landesman Y; Weiss RH
Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1179-86. PubMed ID: 25234309
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation.
Fan LX; Li X; Magenheimer B; Calvet JP; Li X
Kidney Int; 2012 Jan; 81(1):76-85. PubMed ID: 21900881
[TBL] [Abstract][Full Text] [Related]
32. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
[TBL] [Abstract][Full Text] [Related]
33. Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1.
Wang E; Hsieh-Li HM; Chiou YY; Chien YL; Ho HH; Chin HJ; Wang CK; Liang SC; Jiang ST
J Pathol; 2010 Nov; 222(3):238-48. PubMed ID: 20814903
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
[TBL] [Abstract][Full Text] [Related]
35. CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.
Amura CR; Brodsky KS; Gitomer B; McFann K; Lazennec G; Nichols MT; Jani A; Schrier RW; Doctor RB
Am J Physiol Cell Physiol; 2008 Mar; 294(3):C786-96. PubMed ID: 18199703
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-β inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells.
Elberg D; Jayaraman S; Turman MA; Elberg G
Exp Cell Res; 2012 Aug; 318(13):1508-16. PubMed ID: 22504005
[TBL] [Abstract][Full Text] [Related]
37. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice.
Park EY; Sung YH; Yang MH; Noh JY; Park SY; Lee TY; Yook YJ; Yoo KH; Roh KJ; Kim I; Hwang YH; Oh GT; Seong JK; Ahn C; Lee HW; Park JH
J Biol Chem; 2009 Mar; 284(11):7214-22. PubMed ID: 19098310
[TBL] [Abstract][Full Text] [Related]
38. Berberine slows cell growth in autosomal dominant polycystic kidney disease cells.
Bonon A; Mangolini A; Pinton P; Del Senno L; Aguiari G
Biochem Biophys Res Commun; 2013 Nov; 441(3):668-74. PubMed ID: 24184483
[TBL] [Abstract][Full Text] [Related]
39. Concomitant use of rapamycin and rosiglitazone delays the progression of polycystic kidney disease in Han:SPRD rats: a study of the mechanism of action.
Liu C; Li H; Gao X; Yang M; Yuan L; Fu L; Wang X; Mei C
Am J Physiol Renal Physiol; 2018 May; 314(5):F844-F854. PubMed ID: 26911848
[TBL] [Abstract][Full Text] [Related]
40. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic
Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]